Ângela Sousa

Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy

Vítor M. Gaspar, Ilídio J. Correia, Ângela Sousa et al. · Journal of Controlled Release · 2011 · 66 citations

Nanomedicine, Gene Therapies, Dna Nanotechnology +8

Differential interactions of plasmid DNA, RNA and genomic DNA with amino acid‐based affinity matrices

Ângela Sousa, Fani Sousa, João A. Queiroz · Journal of Separation Science · 2010 · 44 citations

Cancer gene therapy mediated by RALA/plasmid DNA vectors: Nitrogen to phosphate groups ratio (N/P) as a tool for tunable transfection efficiency and apoptosis

Ana R. Neves, Ângela Sousa, Rúben Faria et al. · Colloids and Surfaces B Biointerfaces · 2019 · 39 citations

Tunable Transfection Efficiency, Natural Sciences, Molecular Biology +10

Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications

Ângela Sousa, Cândida T. Tomaz, Fani Sousa et al. · Journal of Chromatography A · 2011 · 37 citations

Dna Nanotechnology, Monolithic Innovative Technology, Engineering +7

Purification of human papillomavirus 16 E6/E7 plasmid deoxyribonucleic acid-based vaccine using an arginine modified monolithic support

Alexandra Soares, João A. Queiroz, Fani Sousa et al. · Journal of Chromatography A · 2013 · 37 citations

Vaccination, Vaccine Development, Cervical Cancer +12